General equations are given for computing the results of any (j+j) dose parallel line biological assay based on an incomplete block design. Only the information from comparisons within blocks is used. The computation is illustrated numerically by means of a (2+2) assay of gastrin devised and performed by Lai (1962) , in which-only three of the four doses could be given to each animal.
The aim of this paper is to illustrate the use of balanced incomplete block designs for biological assay.
The method of computation is illustrated using results obtained by Lai (1962) , who used a (2+2) dose Youden square design for the assay of gastrin. The equations given are, however, generally valid for any (j+j) dose biological assay based on a balanced incomplete block design. Catalogues of such designs are given by Cochran & Cox (1957) and by Fisher & Yates (1957) .
Only that part of the computation based on comparisons within blocks is given, partly for simplicity and partly because, as explained below, more elaborate calculations would frequently yield little extra information (as in the present example).
THE NATURE OF THE DESIGN
The assay to be described is of the (2 +2) type, that is it uses two doses of the standard preparation of gastrin and two of the preparation of unknown potency. Obviously it would be best to give all four doses to each rat (using as many rats as are necessary for the accuracy required) so that the estimate of potency of the unknown preparation is not biased by differences in sensitivity to gastrin between the individual rats. Thus a randomized block or Latin square design would normally be used. However, Lai (1962) found it impracticable to obtain from each animal responses to more than three of the four treatments. The duration of action of each dose was such that if all four were given to the same animal responses would have had to be so close together that they would interact, or else the assay would have had to be impossibly long. Consequently the fourth dose had to be carried over to a different animal.
The aim of the method of calculation used is to give, with as little computation as possible, an estimate of the potency of the unknown preparation unbiased by differences between rats, limits of error for this estimate, and tests of the validity of the assay.
The Youden square (Youden, 1937 (Youden, , 1940 ) is a member of the class of experimental designs known as balanced incomplete blocks (Yates, 1936 (Yates, , 1940 . The blocks (in this instance individual rats) are incomplete because each contains fewer than the total number of treatments; only three out of four in the present analysis. The design is said to be balanced when, as in the present example, each treatment is given an equal number of times and each possible pair of treatments is given to the same number (A) of rats (for the design in Table 1 , two rats). Order
The characteristic feature of Youden squares (which are really rectangles) is that, as in Latin squares, every treatment occurs in each column, and in any given column each treatment occurs equally often. In fact the designs are incomplete Latin squares and the example in Table 1 can be formed by omission of one column from a 4x4 Latin square. As the columns represent the order in which doses are given, the means of the columns can be used to judge whether there is any systematic difference between responses to the first, second and third doses of the day. Table la shows the basic design employed by Lai (1962) , using four rats. Table lb  gives a particular case of Table la . It should be randomized by re-arranging the order of the rows, and then of the columns in a sequence taken from a table of random numbers (for example Fisher & Yates, 1957) . The resulting design will still be a particular case of that in Table la .
The treatments are next assigned randomly to the letters. Say, in the present example, A=_HS, Bz-LS, CHT and DeLT, where HS and LS are the high and low doses of the standard preparation and HT and LT are the high and low doses of the test (unknown) preparation. Thus according to the scheme in Table lb For the results in Table 2 : t=4,jj=2, r=3, k=3, b=4 and N=12. The standard doses were 11.0 and 5.5 ,ug of a purified preparation of hog gastrin, so D=2. The " unknown" solution was actually made from the same preparation in this assay, and contained 1,100 uag/ml.; it was given in doses of 0.00750 and 0.00375 ml. The response was the mean rate of acid secretion (pequiv./10 min).
The computations can be divided into four parts:
Corrected mean responses
To compute, for each treatment, the mean response corrected for the bias introduced by the differences between rats, the quantity Q is first formed for each treatment.
Qj, the Q for the ith treatment, is defined as Qi=k (sum of responses for the ith treatment) -(sum of the block sums for those blocks that contain the ith treatment)
Use of the values in Table 2 The results can be checked by making sure that the sum of the Q's is zero.
The corrected mean response to the ith treatment is, in general, These corrected means, and the uncorrected means given in Table 2b , are plotted in Fig. 1 . It can be seen that in this assay the uncorrected response/log dose lines are seriously non-parallel, but after correction the deviation from parallelism is insignificant (as indicated by the analysis of variance below) so a valid estimate of relative potency can be made.
Tests for invalidity. The analysis of variance
Before the result is calculated it should be shown that the assay is not demonstrably invalid, as is done in the usual analysis of bioassays. Obviously it is impossible to test for deviation from linearity in a (2+2) assay. However, it has been shown (Lai, 1962) that, in his gastrin assay, deviation from linearity is not significant over a range of response wider than that used in the present assay.
The general form of the part of the analysis of variance to be described is shown in Table 3 . The results for the present assay are given in Table 4 . The sum of squares for each source of variability is computed first, and entered in Table 4 . This sum of squares can now be split into independent components which provide the tests for invalidity, as indicated in Table 3 . The individual sums of squares are found via the contrasts which are so defined that, on the null hypotheses that the slope, deviation from parallelism, etc., are zero, the contrasts would, on the average, be zero. Table 4 . In the present example the variance ratio for " order of administration" is 0.0410/0.0158-=2.59 with 2 degrees of freedom in the numerator and 3 in the denominator. Although this corresponds to P>0.2 it is not a small enough variance ratio to comply with the criterion of Paull (1950) for the pooling of variances. However, Lai (1962) has only once detected any apparent difference between columns in thirty-four assays similar to that described here, and over half these assays gave variance ratios for " order" of less than 1.0. Also in two larger (12-rat) assays the variance ratios for " order" were F(2,19)=1.066 and 0.334, easily complying with Paull's recommendation. In the light of these values it was decided that there was no reason to believe that response depended at all on the order of administration of doses and that, in order to increase the power of the analysis, the sums of squares for columns and for error should be pooled. The pooled estimate of error thus becomes (0.0821+0.0475)1(2+3) = 0.02592 with (2+3)=5 degrees of freedom. It is this error variance which is now used to form the variance ratios in Table 4 .
It is seen from Table 4 that there is no reason to consider the assay invalid, so the potency ratio and its limits of error can now be computed.
The potency ratio This is calculated from the corrected means for treatments. When the contrasts L1 and L. are defined as above, the equation for the potency ratio reduces to the usual form for a (j +j) assay (see, for example, Finney, 1952) :
where R is the potency ratio, ZSIZT is the ratio of standard dose to unknown dose, c is defined in equations (1) and (2), and r= V1D if j is even 
The factor log10r occurs because the calculations have implicitly used the logarithms to base r of the doses. In the present example this makes both (Xs -X-) and (XT-XT) take the value -1 for the low doses and + 1 for the high doses (see Fig. 1 ). = 1,213 izg/ml. As the true potency of this solution was 1,100 ,pglml. this estimate is about 10 % high.
The fiducial limits of the potency ratio
The limits of error computed for the potency ratio are such that if it is consistently asserted that the true potency of the unknown solution lies between the limits then, on the average, 95 % (or any other chosen proportion) of such assertions will be correct.
The limits are computed by means of Fieller's theorem (Fieller, 1944; Finney, 1952, p. 27 ) which is applied, as usual, to the ratio (YT-Ys)IbC. For a (1+1) dose incomplete block assay this ratio is equal to cLPIL1, when c, Lp and L1 are defined as in the previous sections. The theorem can be written: zI
where g= bS2 , an index of significance of the slope, bc; c is defined by equations (1) and (2); r is defined by equations (3) and (4) (Finney, 1952 Finney (1952, Table 10.7, p. 275) . In the case of the assay of purified hog gastrin and crude human gastrin Lai (1962) has shown that residual effects are negligible and that four rats give adequate accuracy for most purposes. However, in responses to crude hog gastrin residual effects were quite noticeable, and if it were required to assay this material the 12-rat balanced design might be useful.
With four rats Lai found the 95 % fiducial limits of the potency ratio were usually between ± 15 and ±20 %. In a 12-rat assay, using a preparation of known potency, the potency estimate was only 1.4% in error with fiducial limits of ± 12.3%.
Efficiency of the design. When not all of the treatments can be compared in the same block the comparisons between block totals will contain a certain amount of " interblock " information about treatment effects, which has been ignored in the simple analysis above. The efficiency of a balanced incomplete block design is, in general, defined as [t(k-1)/k(t-1)] (Yates, 1936) , that is about 89% in the present example. This means that if the error variance in the present example were the same as the error variance which would be found if all four treatments could be given to each rat, the variance of comparisons between treatments based on the latter design would be about 89% of the variance of comparisons based on the present design. However, since the four treatments cannot be given to each rat, the incomplete block design is much more efficient than any available alternative.
Recovery of interblock information. When the number of blocks is greater than the number of treatments (as, in the present example, when more than four rats are used) an independent estimate of potency can be obtained from the interblock information about treatment effects. This estimate is combined with the intrablock estimate already obtained to form a weighted mean potency estimate.
Data from assays based on eight and twelve rats have been further analysed by splitting the sum of squares for blocks (ignoring treatments) into a treatment component with (t-1) degrees of freedom and an interblock error with (b-t) degrees of freedom (see, for example, Fisher & Yates, 1957, Introduction) . The treatment component can then be divided into contrasts in a way analogous with that used for the sum of squares for treatments eliminating rats. From these contrasts the interblock potency estimate is computed.
However, because of the initial high efficiency of the particular incomplete block design used for the gastrin assay, and because of the considerable differences between rats, no significant amount of information was recovered by the interblock analysis even when twelve rats were used. Even in far larger assays the interblock estimate would have so much less weight than the intrablock estimate that it is doubtful whether its use would, in the case of the gastrin assay, result in any worthwhile improvement on the simple intrablock estimate of potency described above.
It is possible that in assays based on less efficient designs than that used in the present example, or in assays where there is not much difference between blocks, the interblock information might be worth recovering even though its use means that the fiducial limits for the potency ratio must be based on less universally accepted theory than that used in the simple analysis. Finney (1952) describes the calculations for a (3+3) assay with two treatments per block. Bliss (1947) gives the analyses for two balanced incomplete block designs which are also cross-over designs, with recovery of interblock information by the more elaborate method of Yates (1940) .
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